INDV Indivior Earnings and EPS analysis

Relative Growth: Rel. Growth: 76

Relative Strength: Rel. Strength: 86

Relative Valuation: Rel. Valuation: 82

Relative Profitability: Rel. Profitability: 83

EPS in 2026 (TTM): $2.01

Last Report Period Date: Mar 31, 2026

Based on the company's latest reports for March 2026, the current 12-month EPS is $2.01. Indivior's earnings per share in 2025 was reported at $1.68, marking a rise from $0.05 in 2024. In the quarterly report ending on Mar 31, 2026, INDV's earnings per share amounted to $0.71.

INDV earnings history

Historical annual and quarterly earnings per share (EPS) data for Indivior

EPS (TTM)

$2.01

EPS Growth YoY (Quarterly)

86.8%

EPS (Quarterly)

$0.71

EPS Growth (Quarterly)

-12.3%

Indivior had an yealy earnings per share of $1.68, showing a rise of 3,260% from $0.05 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $0.71, showing a 86.8% increase compared to the same quarter last year. The trailing twelve months EPS for INDV is $2.01 as of March 2026. Indivior's full-year EPS for 2024 was $0.05, a 105.4% rise compared to the previous year.

INDV earnings chart

INDV EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

86.8%

EPS growth YoY

3,260%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

In the past 12 months, Indivior has recorded an earnings per share growth rate of 86.8% (YoY, quarterly).

INDV Earnings Waterfall

Breakdown of revenue, profit and net income for Indivior

INDV Earnings vs Peers

What are the earnings of INDV compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
INDV Indivior Plc	18.63	3,260%	N/A	N/A
TEVA Teva Pharmaceutical Industries Ltd	24.93	184.8%	N/A	N/A
AMRX Amneal Pharmaceuticals Inc	34.67	160.5%	N/A	-18%
PRGO PERRIGO Co plc	N/A	-723.2%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.